Financhill
Buy
71

VUZI Quote, Financials, Valuation and Earnings

Last price:
$4.39
Seasonality move :
30.62%
Day range:
$3.34 - $4.49
52-week range:
$0.83 - $4.72
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
52.06x
P/B ratio:
8.20x
Volume:
4.3M
Avg. volume:
2.6M
1-year change:
97.53%
Market cap:
$324.3M
Revenue:
$12.1M
EPS (TTM):
-$1.23
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $6.7M $11.6M $13.2M $11.8M $12.1M
Revenue Growth (YoY) -17.59% 73.62% 13.67% -10.1% 2.48%
 
Cost of Revenues $11.1M $11M $11.6M $10.4M $14.8M
Gross Profit -$4.4M $598K $1.6M $1.5M -$2.6M
Gross Profit Margin -66.08% 5.16% 11.91% 12.53% -21.72%
 
R&D Expenses $8.9M $7.6M $11.7M $12.7M $12.3M
Selling, General & Admin $10.8M $11M $28.6M $29.1M $31.3M
Other Inc / (Exp) $200.1K $1.2M -$353.5K $1.5M $204.6K
Operating Expenses $22.3M $19.8M $41.6M $43.8M $47.7M
Operating Income -$26.7M -$19.2M -$40M -$42.3M -$50.4M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$26.5M -$18M -$40.4M -$40.8M -$50.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$26.5M -$18M -$40.4M -$40.8M -$50.1M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$26.5M -$18M -$40.4M -$40.8M -$50.1M
 
Basic EPS (Cont. Ops) -$0.94 -$0.53 -$0.66 -$0.64 -$0.79
Diluted EPS (Cont. Ops) -$0.94 -$0.53 -$0.66 -$0.64 -$0.79
Weighted Average Basic Share $30.3M $38.1M $61.1M $63.7M $63.4M
Weighted Average Diluted Share $30.3M $38.1M $61.1M $63.7M $63.4M
 
EBITDA -$24.1M -$16.5M -$37.7M -$39.7M -$45.4M
EBIT -$26.7M -$19.2M -$40M -$42.3M -$50.4M
 
Revenue (Reported) $6.7M $11.6M $13.2M $11.8M $12.1M
Operating Income (Reported) -$26.7M -$19.2M -$40M -$42.3M -$50.4M
Operating Income (Adjusted) -$26.7M -$19.2M -$40M -$42.3M -$50.4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $2.8M $3M $3.4M $2.2M $1.4M
Revenue Growth (YoY) 139.78% 8.64% 13.52% -36.38% -36.44%
 
Cost of Revenues $2.4M $2.6M $2.6M $2.4M $1.6M
Gross Profit $348K $396K $868.2K -$237.5K -$259.9K
Gross Profit Margin 12.52% 13.12% 25.34% -10.9% -18.75%
 
R&D Expenses $1.9M $3.4M $3.4M $2.9M $2.3M
Selling, General & Admin $2.6M $7.1M $6.8M $7.3M $6.1M
Other Inc / (Exp) -$11.8K -$123.2K $460.1K $447.1K -$60K
Operating Expenses $5.1M $10.8M $10.8M $11.2M $8.9M
Operating Income -$4.7M -$10.4M -$9.9M -$11.4M -$9.2M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$4.8M -$10.5M -$9.5M -$11M -$9.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$4.8M -$10.5M -$9.5M -$11M -$9.2M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$4.8M -$10.5M -$9.5M -$11M -$9.2M
 
Basic EPS (Cont. Ops) -$0.13 -$0.17 -$0.15 -$0.17 -$0.14
Diluted EPS (Cont. Ops) -$0.13 -$0.17 -$0.15 -$0.17 -$0.14
Weighted Average Basic Share $39.8M $63.5M $63.8M $63.3M $67.8M
Weighted Average Diluted Share $39.8M $63.5M $63.8M $63.3M $67.8M
 
EBITDA -$4.1M -$9.9M -$9.2M -$10.2M -$8.5M
EBIT -$4.7M -$10.4M -$9.9M -$11.4M -$9.2M
 
Revenue (Reported) $2.8M $3M $3.4M $2.2M $1.4M
Operating Income (Reported) -$4.7M -$10.4M -$9.9M -$11.4M -$9.2M
Operating Income (Adjusted) -$4.7M -$10.4M -$9.9M -$11.4M -$9.2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $9.3M $14.1M $12.3M $14M $5.5M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $12.4M $12.7M $10.6M $12.5M $10.4M
Gross Profit -$3.1M $1.4M $1.7M $1.5M -$4.9M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $7.8M $10.2M $12.9M $12M $11M
Selling, General & Admin $10.4M $24.1M $28.8M $29.7M $28.7M
Other Inc / (Exp) -$3.5K $934.3K $392.4K $2.9M -$31.5M
Operating Expenses $20.8M $34.8M $43.5M $45.4M $43.3M
Operating Income -$23.9M -$33.4M -$41.9M -$43.9M -$48.2M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$23.9M -$32.5M -$41.5M -$41M -$79.8M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$23.9M -$32.5M -$41.5M -$41M -$79.8M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$23.9M -$32.5M -$41.5M -$41M -$79.8M
 
Basic EPS (Cont. Ops) -$0.75 -$0.58 -$0.74 -$0.64 -$1.23
Diluted EPS (Cont. Ops) -$0.75 -$0.58 -$0.74 -$0.64 -$1.23
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -$21.1M -$31.2M -$39.4M -$39.5M -$43.7M
EBIT -$23.9M -$33.4M -$41.9M -$43.9M -$48.2M
 
Revenue (Reported) $9.3M $14.1M $12.3M $14M $5.5M
Operating Income (Reported) -$23.9M -$33.4M -$41.9M -$43.9M -$48.2M
Operating Income (Adjusted) -$23.9M -$33.4M -$41.9M -$43.9M -$48.2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $7.3M $9.9M $8.9M $11.1M $4.5M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $6.1M $7.8M $7.3M $9.5M $5.1M
Gross Profit $1.2M $2.1M $1.6M $1.6M -$646.3K
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $5.7M $8.3M $9.5M $8.8M $7.4M
Selling, General & Admin $7.9M $21M $21.2M $21.7M $19.2M
Other Inc / (Exp) -$65.4K -$336.7K $376.7K $1.7M -$30M
Operating Expenses $15.5M $30.6M $32M $33.6M $29.2M
Operating Income -$14.3M -$28.5M -$30.4M -$32M -$29.9M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$14.4M -$28.9M -$30M -$30.3M -$59.9M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$14.4M -$28.9M -$30M -$30.3M -$59.9M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$14.4M -$28.9M -$30M -$30.3M -$59.9M
 
Basic EPS (Cont. Ops) -$0.44 -$0.49 -$0.47 -$0.47 -$0.92
Diluted EPS (Cont. Ops) -$0.44 -$0.49 -$0.47 -$0.47 -$0.92
Weighted Average Basic Share $109.3M $180.7M $191.2M $189.8M $198.4M
Weighted Average Diluted Share $109.3M $180.7M $191.2M $189.8M $198.4M
 
EBITDA -$12.2M -$26.9M -$28.6M -$28.4M -$26.6M
EBIT -$14.3M -$28.5M -$30.4M -$32M -$29.9M
 
Revenue (Reported) $7.3M $9.9M $8.9M $11.1M $4.5M
Operating Income (Reported) -$14.3M -$28.5M -$30.4M -$32M -$29.9M
Operating Income (Adjusted) -$14.3M -$28.5M -$30.4M -$32M -$29.9M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $10.6M $36.1M $120.2M $72.6M $26.6M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $1.4M $1.4M $2.2M $4M $4M
Inventory $5.7M $6.1M $12.2M $11.3M $9M
Prepaid Expenses $242.5K $485K $504.1K $998.7K $403.8K
Other Current Assets $895.1K $1M $2M $1.5M $1.3M
Total Current Assets $19.1M $45.1M $137.2M $90.6M $41.5M
 
Property Plant And Equipment $6.4M $4.4M $6.3M $4.8M $8.4M
Long-Term Investments $250K $250K $450K $450K $6.4M
Goodwill -- -- -- $1.6M --
Other Intangibles $2.7M $2.8M $4.1M $33.6M $29.8M
Other Long-Term Assets -- -- $491.9K -- --
Total Assets $28.4M $52.5M $148.5M $131.1M $86.1M
 
Accounts Payable $1.1M $1.5M $2.1M $1.2M $1.6M
Accrued Expenses $885.9K $983K $1.4M $1.7M $2.4M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $524.8K $444.5K $534.2K $651K $163.5K
Other Current Liabilities -- -- -- $11.5M $1M
Total Current Liabilities $2.6M $3.1M $4.2M $15.3M $5.2M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $4.2M $4.2M $4.7M $15.6M $5.4M
 
Common Stock $33.2K $45.7K $63.7K $63.8K $65.3K
Other Common Equity Adj -- -- -- -- --
Common Equity $24.2M $48.3M $143.7M $115.5M $80.8M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $24.2M $48.3M $143.7M $115.5M $80.8M
 
Total Liabilities and Equity $28.4M $52.5M $148.5M $131.1M $86.1M
Cash and Short Terms $10.6M $36.1M $120.2M $72.6M $26.6M
Total Debt -- -- -- -- --
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $24.9M $128.7M $90.4M $38M $14.3M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $831.4K $1.1M $3.1M $7M $2.7M
Inventory $6.6M $9.9M $12.2M $11.3M $9.8M
Prepaid Expenses $171K $1.9M $430.7K $621K $308.7K
Other Current Assets $1.4M $2.4M $2.5M $2.2M $1.1M
Total Current Assets $34.2M $144M $109M $59.6M $28.7M
 
Property Plant And Equipment $4.8M $6.6M $10.2M $7.5M $8.5M
Long-Term Investments -- -- $450K $650K $650K
Goodwill -- -- -- $1.6M --
Other Intangibles $2.3M $3.6M $18.3M $31.2M $4M
Other Long-Term Assets $650K $1.4M $725.1K $429.5K --
Total Assets $42.1M $155.5M $138.8M $101M $41.8M
 
Accounts Payable $909.1K $1.5M $2.2M $1.9M $659.3K
Accrued Expenses $874.1K $1.6M $1.2M $838.3K $715.9K
Current Portion Of Long-Term Debt $945K -- -- -- --
Current Portion Of Capital Lease Obligations $444.5K $534.2K $525.9K $296.5K $506.4K
Other Current Liabilities -- -- $4.3M $2M --
Total Current Liabilities $3.3M $3.7M $8.2M $5.1M $2.2M
 
Long-Term Debt $610.9K -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $5M $4.3M $13.1M $5.3M $2.3M
 
Common Stock $42.8K $63.6K $63.8K $63.9K $74.2K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $37M $151.1M $125.6M $95.7M $39.6M
 
Total Liabilities and Equity $42.1M $155.5M $138.8M $101M $41.8M
Cash and Short Terms $24.9M $128.7M $90.4M $38M $14.3M
Total Debt $1.6M -- -- -- --
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -$26.5M -$18M -$40.4M -$40.8M -$50.1M
Depreciation & Amoritzation $2.5M $2.6M $2.3M $2.6M $4.9M
Stock-Based Compensation $1.5M $2.8M $17.3M $15.8M $12.7M
Change in Accounts Receivable -$599.6K -$289.4K -$853.6K -$2.1M -$1.5M
Change in Inventories -$3M -$1.7M -$6.6M $593.6K -$2.1M
Cash From Operations -$22.4M -$14M -$27M -$24.5M -$26.3M
 
Capital Expenditures $2.9M $1.5M $4.9M $18.9M $16.6M
Cash Acquisitions -- -- -- -$2.3M --
Cash From Investing -$3.2M -$1.5M -$4.9M -$21.2M -$19.3M
 
Dividends Paid (Ex Special Dividend) -- -- -$10M -- --
Special Dividend Paid
Long-Term Debt Issued -- $1.6M -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -$2M -$470.8K
Other Financing Activities -- -- -$1.1M -- --
Cash From Financing $18.9M $40.9M $116M -$1.9M -$449.6K
 
Beginning Cash (CF) $17.3M $10.6M $36.1M $120.2M $72.6M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$6.7M $25.5M $84.1M -$47.6M -$46M
Ending Cash (CF) $10.6M $36.1M $120.2M $72.6M $26.6M
 
Levered Free Cash Flow -$25.3M -$15.4M -$31.8M -$43.4M -$42.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$4.8M -$10.5M -$9.5M -$11M -$9.2M
Depreciation & Amoritzation $680.5K $494.4K $731.9K $1.2M $642.8K
Stock-Based Compensation $1.1M $4.2M $3.8M $3.3M $3.2M
Change in Accounts Receivable $374.5K $40.5K -$1.8M -$533.8K -$101.4K
Change in Inventories -$307.2K -$2M -$437.4K -$436.6K $412.4K
Cash From Operations -$2.4M -$5.8M -$6.9M -$8M -$5.3M
 
Capital Expenditures $518.6K $3.1M $3.3M $2.5M $332.7K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$518.6K -$3.1M -$3.3M -$2.5M -$332.7K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- $10M
Cash From Financing $14.6M $44.7K -- $6.7K $10M
 
Beginning Cash (CF) $13.2M $137.6M $100.6M $48.6M $9.9M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $11.7M -$8.9M -$10.2M -$10.5M $4.4M
Ending Cash (CF) $24.9M $128.7M $90.4M $38M $14.3M
 
Levered Free Cash Flow -$2.9M -$8.9M -$10.2M -$10.5M -$5.6M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$23.9M -$32.5M -$41.5M -$41M -$79.8M
Depreciation & Amoritzation $2.8M $2.2M $2.5M $4.4M $4.6M
Stock-Based Compensation $2.3M $13.6M $16.5M $13.6M $11.4M
Change in Accounts Receivable -$182.1K -$37.9K -$2.5M -$3.9M $2.1M
Change in Inventories -$2.3M -$4.6M -$2.9M $152K -$2.4M
Cash From Operations -$15.6M -$21.6M -$26M -$26.7M -$25.9M
 
Capital Expenditures $1.6M $4.7M $12.2M $20.9M $5.4M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$1.9M -$4.7M -$12.2M -$23.4M -$7.9M
 
Dividends Paid (Ex Special Dividend) -- -$10M -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -$251.1K -$2.2M --
Other Financing Activities -- -- -- -- --
Cash From Financing $26.8M $130.1M -$162.3K -$2.2M $10M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $9.3M $103.8M -$38.4M -$52.3M -$23.8M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$17.2M -$26.3M -$38.2M -$47.6M -$31.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$14.4M -$28.9M -$30M -$30.3M -$59.9M
Depreciation & Amoritzation $2.1M $1.6M $1.8M $3.6M $3.3M
Stock-Based Compensation $2M $12.8M $12M $9.8M $8.5M
Change in Accounts Receivable $78.6K $330.1K -$1.3M -$3.1M $496K
Change in Inventories -$855.6K -$3.8M -$77.5K -$519.1K -$825.3K
Cash From Operations -$11.3M -$18.9M -$17.9M -$20.1M -$19.7M
 
Capital Expenditures $1.2M $4.3M $11.7M $13.7M $2.6M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$1.2M -$4.3M -$11.7M -$13.9M -$2.6M
 
Dividends Paid (Ex Special Dividend) -- -$10M -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $1.6M -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -$251.1K -$470.8K --
Other Financing Activities -- -$1.1M -- -- $10M
Cash From Financing $26.8M $115.9M -$202.6K -$449.6K $10M
 
Beginning Cash (CF) $30M $306.4M $334.1M $184.4M $52.9M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $14.3M $92.7M -$29.8M -$34.5M -$12.3M
Ending Cash (CF) $44.3M $399.1M $304.3M $149.9M $40.7M
 
Levered Free Cash Flow -$12.4M -$23.2M -$29.6M -$33.9M -$22.3M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock